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The C-type lectin receptors (CLRs) Mincle, Mcl, and Dectin-2 bind mycobacterial and 
fungal cell wall glycolipids and carbohydrates. Recently, we described that expression 
of these CLR is downregulated during differentiation of human monocytes to dendritic 
cells (DC) in the presence of GM-CSF and IL-4. Here, we demonstrate that the Th2 
cytokine IL-4 specifically inhibits expression of Mincle, Mcl, and Dectin-2 in human anti-
gen-presenting cells (APC). This inhibitory effect of IL-4 was observed across species, as 
murine macrophages and DC treated with IL-4 also downregulated these receptors. IL-4 
blocked upregulation of Mincle and Mcl mRNA expression and cell surface protein by 
murine macrophages in response to the Mincle ligand Trehalose-6,6-dibehenate (TDB), 
whereas the TLR4 ligand LPS overcame inhibition by IL-4. Functionally, downregulation 
of Mincle expression by IL-4 was accompanied by reduced cytokine production upon 
stimulation with TDB. These inhibitory effects of IL-4 were dependent on the transcription 
factor Stat6. Together, our results show that the key Th2 cytokine IL-4 exerts a negative 
effect on the expression of Mincle and other Dectin-2 cluster CLR in mouse and human 
macrophages and DC, which may render these sentinel cells less vigilant for sensing 
mycobacterial and fungal ligands.
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inTrODUcTiOn
Following the identification of Dectin-1 as a Syk-coupled activating receptor for bacterial and 
fungal beta-glucans 15 years ago (1), C-type lectin receptors (CLRs) have received increasing atten-
tion as pattern recognition receptors of the innate immune system. The CLR Dectin-2, Mincle, 
and Mcl belong to the so-called Dectin-2 family with their genes adjacent to each other in the 
NK cell receptor gene cluster, localized on human chromosome 12 and mouse chromosome 6 (2). 
Abbreviations: CLR, C-type lectin receptor; FcRγ, Fc receptor gamma chain; IL-4, Interleukin-4; Mincle, macrophage-
inducible-C-type-lectin; Mcl, macrophage C-type lectin; SYK, spleen tyrosine kinase; TDB, trehalose-6,6-dibehenate; TDM, 
trehalose-6,6-dimycolate.
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These  three  receptors  recognize mycobacterial and/or fungal 
ligands, are expressed constitutively or inducibly on innate 
immune cells, and have an emerging role in innate immunity to 
these infections.
Mincle (official gene symbol Clec4e, aka Clecsf9) not only binds 
the mycobacterial cord factor trehalose-6,6-dimycolate (TDM) 
(3, 4), related synthetic glycolipids such as the adjuvant trehalose-
6,6-dibehenate (TDB) (3, 4), but also fungal ligands derived from 
Candida albicans (5–7), Malassezia furfur (8, 9), or Fonsecaea 
spp. (10, 11). More recently, Mcl (official gene symbol Clec4d, 
aka Clecsf8) was identified as a second, low affinity-receptor for 
the mycobacterial cord factor (12), which is required for efficient 
control of experimental mycobacterial infection in mice (13), but 
did not bind to sugar ligands on carbohydrate microarrays (14). 
In contrast, Dectin-2 (gene symbol Clec4n in mice, CLEC6A in 
humans) not only has a classical C-type lectin domain that binds 
structures with high mannose content from numerous pathogens, 
most notably Candida albicans (15, 16), but also mycobacterial 
manLAM (17) and schistosomal egg antigen (18).
Whereas Dectin-1 directly recruits the kinase Syk via a non-
classical ITAM motif in its intracellular domain, Mincle, Mcl, 
and Dectin-2 all associate with the ITAM-containing adapter 
protein Fc receptor gamma chain (FcRγ) to initiate signaling 
through the Card9/Bcl10/Malt1 complex (19). Activation of 
NFκB and MAPK pathways triggers substantial reprograming 
of gene expression in macrophages after activation of Mincle by 
TDB, similar to Curdlan-induced Dectin-1 activation, but only 
partially overlapping with inflammatory gene expression induced 
by TLR ligands (20). Similar to Curdlan, activation of APC by 
TDB or TDM directs a cytokine milieu fostering the development 
of Th17 responses to co-delivered protein antigens via produc-
tion of IL-6, IL-23, and IL-1 (4, 20–24).
Expression of Mincle is strongly inducible in murine mac-
rophages and DC by PAMPs, such as the TLR4 ligand LPS (25) 
or by its ligand TDM itself (4, 12), and depends on the transcrip-
tion factor C/EBPβ (25, 26). Interestingly, Mincle expression 
is constitutively high in murine monocytes and granulocytes 
(21,  27), similar to human monocytes and macrophages (28). 
In  contrast, expression of Mcl is constitutively higher in mouse 
bone marrow-derived macrophages (BMM) and bone marrow-
derived dendritic cells (BMDC), and inducible to a lesser extent 
(12, 26). Dectin-2 expression is predominantly myeloid restricted 
and upregulated by inflammatory stimuli (16). Cytokines involved 
in the upregulation of Dectin-2 include TNF or GM-CSF (29).
IL-4 is the prototypical Th2 cytokine and induces alternative 
macrophage activation through the transcription factor Stat6 
(30). Interestingly, Th2 responses and IL-4 driven alternative 
macrophage activation have been associated with poorer out-
comes in fungal (31) and in mycobacterial infection (32, 33). It is 
well established that IL-4 induces the expression of Dectin-1 (34). 
Its effects on the expression of other CLRs are not well character-
ized, although downregulation of Dectin-2 expression in IL-4 
treated human CD14+ monocytes has been described (29).
We recently observed a strong downregulation of the mRNA 
expression of Mincle, Mcl, and Dectin-2 during differentiation of 
human DC from CD14+ monocytes in the presence of GM-CSF 
and IL-4 in  vitro (28). Here, we investigated the regulation of 
expression of these CLRs by IL-4 in human and mouse APC. 
Our data show that IL-4 specifically downregulates Mincle, Mcl, 
and Dectin-2 expression, but not Dectin-1 expression, in both 
species and impairs Mincle-dependent macrophage activation in 
response to the cord factor analog TDB.
MaTerials anD MeThODs
isolation and culture of human  
antigen-Presenting cells
The use of human leukocytes from healthy donors with written 
informed consent complies with the Declaration of Helsinki 
(Ethical committee Erlangen approval no. 4055 and no. 111_12 B). 
PMBCs were obtained from leukoreduction system chambers by 
density centrifugation (35). Monocytes were positively selected 
from PBMC using α-CD14 microbeads (Miltenyi Biotec), purity 
was ≥90%. For culture, RPMI1640 was supplemented with 10% 
(v/v) fetal calf serum (FCS, Biochrom) and 100 U/ml penicillin 
and 100 μg/ml streptomycin (cRPMI). A total of 50 U/ml GM-CSF 
(Genzyme) or 50 U/ml M-CSF (Peprotech) were added for dif-
ferentiation of macrophages. 50  U/ml GM-CSF and 250  U/ml 
IL-4 (Peprotech) were added for differentiation of DC. Cells were 
cultured at a density of 0.8 × 106 cells/ml (GM-CSF macrophages, 
DC) or 1.6 ×  106 cells/ml (M-CSF macrophages) for 6–7  days 
without change of media at 37°C with 5% CO2 humidified air.
isolation and culture of Mouse 
Macrophages and Dc
C57BL/6, Clec4e−/−, Balb/c, and Stat6−/− mice were bred at the 
Präklinische Experimentelle Tierzentrum of the Medical Faculty 
of the Friedrich-Alexander-University Erlangen-Nürnberg. Mice 
were housed and humanely sacrificed according to regional 
government regulations. Bone marrow cells from femurs and 
tibiae were differentiated to macrophages by culture in complete 
Dulbecco’s Modified Eagle Medium containing 10% FCS, antibi-
otics, and 50 μM β-mercaptoethanol (cDMEM) plus 10% L929-
cell conditioned medium as a source of M-CSF, as previously 
described (36). On day 7, adherent macrophages were harvested 
by Accutase (Sigma) treatment, washed and counted. For gen-
eration of BMDC, bone marrow cells were cultured in cDMEM 
containing 10% conditioned medium of X63 cells producing 
GM-CSF for 7–8 days before harvesting. Peritoneal exudate cells 
(PEC) were obtained on day 4 after injection of mice with 2 ml 
of 4% thioglycollate by flushing the peritoneal cavity with 10 ml 
of ice-cold PBS.
cell stimulation
Human antigen-presenting cells were stimulated by adding 
M-CSF (Peprotech, 50 U/ml), GM-CSF (Genzyme, 50 U/ml), or 
IL-4 (Peprotech, 250  U/ml unless otherwise stated) to the cell 
culture medium before plating of cells into 48 well cell-culture 
plates in a concentration of 0.85  ×  106/ml. Mouse antigen-
presenting cells were stimulated with 10 ng/ml IL-4 (Peprotech), 
10  ng/ml LPS (E. coli serotype O55:B5, Sigma) by adding the 
substance to the cell culture medium before plating of the cells 
into 24 well cell-culture plates in a concentration of 0.5 × 106/ml. 
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TDB (Polar Avanti, 5 μg/ml) was used plate-bound as previously 
described (4, 37), coating with isopropanol only was used as a 
negative control.
mrna expression analysis of clrs
RNA was isolated with Trifast (Peqlab), cDNA was transcribed 
using a cDNA synthesis kit (Applied Biosystems). Expression 
levels of the housekeeping genes hypoxanthine-guanin-
phosphoribosyltransferase (Hprt, mouse) or cyclophilin A 
(PPIA, human), as of the genes of interest, were analyzed using 
primer/probe combinations selected from the Roche Universal 
Probe Library (Roche). For human MINCLE, the primer/probe 
combination was selected using the software PrimerExpress 
(Applied Biosystems). All primers and probes used have been 
described (28) and were purchased from Metabion. ΔCT values 
were calculated as ΔCT = CT(housekeeping gene) − CT(gene of interest) (such 
that higher values indicate higher relative expression), and ΔΔCT 
values referred to the calibrator as indicated.
cytokine elisa
Cytokine concentration of murine G-CSF and TNF-α was ana-
lyzed by sandwich ELISA (DuoSet ELISA, R&D Systems) using 
cell-free cell culture supernatants of cells stimulated as indicated.
Flow cytometry of Mincle and Mcl surface 
receptor levels
The 2 × 105 BMM of C57BL/6 and Mincle−/− mice were stimu-
lated with LPS (10 ng/ml) or TDB (5 μg/ml) in the presence or 
absence of IL-4 (10 ng/ml), as well as with IL-4 alone, for 16 h in 
F-bottom 96 well cell-culture plates. Cell surface expression of 
Mincle and Mcl was analyzed by flow cytometry. Staining was 
performed by using anti-Mincle (clone 4A9, MBL) and anti-Mcl 
(clone 3A4) (38) as primary antibodies, and anti-rat IgG1 con-
jugated to APC as secondary antibody (eBioscience) in a final 
concentration of 1 μg/ml for anti-Mincle and anti-rat IgG-APC 
or 2.27 μg/ml for anti-Mcl. Fc receptors were blocked by adding 
anti-mouse CD16/32 (clone 93, eBioscience) in a final concentra-
tion of 2.5 μg/ml before staining. Cells were stained with primary 
antibodies for 20  min at 4°C, washed, and then stained with 
secondary antibody for 20 min at 4°C. Flow cytometry data were 
acquired on a FACSCanto II instrument (BD); analysis was car-
ried out using FlowJo (version 10).
statistics
Statistical analysis was performed using Prism5 (GraphPad 
Software, v5.01). Student’s t-test was applied as indicated for 
non-paired and paired testing between two groups. *p <  0.05, 
**p < 0.01, ***p < 0.001, ns p > 0.05.
resUlTs
il-4 Downregulates Mincle expression  
in human Monocyte-Derived aPc
In our recent characterization of CLR expression on pri-
mary human antigen-presenting cells, we observed higher 
expression of MINCLE mRNA in macrophages generated 
with M-CSF or GM-CSF compared to DC differentiated in 
the presence of GM-CSF plus IL-4 (28). This effect was con-
firmed in independent experiments using cells from unrelated 
healthy donors, showing a strong reduction in the ΔCT values 
from around −4.05 (M-CSF) and −5.0 (GM-CSF) to −10.4 
(GM-CSF + IL-4) (Figure 1A). Quantitative RT-PCR analysis 
of mRNA expression for a range of CLR showed that the reduced 
expression in DC compared to GM-CSF-derived macrophages 
was selectively observed for MINCLE, MCL, DECTIN2, and 
CLEC12A whereas expression levels of the other tested CLR 
were not significantly different (Figure 1B). Since the presence 
of IL-4 in the cell culture media was the main difference in the 
differentiation protocols for GM-CSF macrophages and DC, 
we tested whether IL-4 alone would be sufficient to downregu-
late MINCLE expression in monocyte cultures (Figure  1C). 
MINCLE expression was highest in freshly isolated CD14+ 
monocytes and declined over time during culture in media 
alone. However, addition of IL-4 caused a stronger reduction, 
and this effect was detectable at all time points tested (6–144 h). 
The presence of GM-CSF kept MINCLE expression at a high 
level, but additional IL-4 induced strong downregulation, which 
was again detectable already after 6h, but increased over time 
(Figure 1C). The inhibitory effect of IL-4 on MINCLE expres-
sion by monocytes was dose dependent and already detected 
with 0.25 U/ml IL-4 but more pronounced at concentrations 
above 2.5 U/ml (Figure 1D). Having shown that IL-4 inhibits 
MINCLE expression in monocytes early during differentia-
tion cultures, we next asked whether the same effect was seen 
when adding IL-4 to macrophages or DC after differentiation. 
While the expression of MINCLE in monocyte-derived DC 
cultured in media only was relatively variable and the reduc-
tion observed for the average values in DC treated with IL-4 
was not significant, both types of macrophages responded with 
significant downregulation of MINCLE when treated with IL-4 
for 48 h (Figure 1E).
il-4 also Downregulates Mincle 
expression in Murine antigen-Presenting 
cells
We next asked whether the regulatory action of IL-4 is conserved 
between species and tested the expression of mouse macrophages 
and DC treated for 48 h with IL-4 (Figure 2). IL-4 was used at 
the saturating concentration of 10  ng/ml (39). Mincle mRNA 
levels in M-CSF-driven BMM under basal conditions were lower 
than those in d4 thioglycollate-elicited peritoneal exsudate cells 
(PEC) or GM-CSF-driven BMDC, but IL-4 decreased Mincle 
expression in all three cell types significantly (Figure 2A). Mcl 
expression was comparably high in untreated BMM, PEC, and 
BMDC and strongly inhibited by IL-4 (Figure  2B). Dectin-2 
mRNA was highest in BMDC and significantly downregulated by 
IL-4 in BMM and BMDC (Figure 2C). In contrast, IL-4 did not 
inhibit Dectin-1 expression in mouse APC, but in fact increased 
Dectin-1 mRNA in BMM, confirming a previous report (34) 
(Figure 2D). Together, the pattern of IL-4 effects on expression 
of the CLR family members examined was very similar between 
FigUre 1 | il-4 downregulates Mincle mrna expression in human antigen-presenting cells. (a) Monocyte-derived DC express less MINCLE than 
monocyte-derived macrophages. Human CD14+ cells were differentiated for 6 days in the presence of M-CSF or GM-CSF (to obtain macrophages) or GM-
CSF + IL-4 (to obtain dendritic cells). After that, MINCLE mRNA levels were measured using qPCR. The data are depicted as mean ± SD of ΔCT values 
(Ct[PPIA] − Ct[MINCLE]) of cells from eight independent blood donors. (B) Reduced expression in DC is restricted to MINCLE, MCL, DECTIN2, and CLEC12A. Gene 
expression of human GM-CSF-elicited macrophages was compared to dendritic cells (induced via GM-CSF + IL-4) after 6 days of differentiation using qPCR. The 
data are depicted as mean ± SD of ΔΔCT values (using GM-CSF Mϕ as calibrators) from 6 independent blood donors. (c) IL-4 is sufficient to reduce MINCLE 
expression in human CD14+ cells. CD14+ peripheral blood mononuclear cells were stimulated as indicated. MINCLE expression was determined using qPCR. The 
data are depicted as mean ± SD (n = 2 for d0, n = 4 for d0.25, and n = 6 for all other time points). Asterisks indicate significant p-values for the comparison “IL-4 
vs. untreated”, crosses for the comparison “GM-CSF + IL-4 vs. GM-CSF”. (D) Dose-dependence of IL-4 effect. CD14+ peripheral blood mononuclear cells were 
stimulated with increasing concentrations of IL-4 for 24 h. Mean ± SD of ΔCT values for MINCLE expression of cells from four independent donors. (e) Human 
CD14+ monocyte-derived M-CSF or GM-CSF elicited macrophages and dendritic cells were stimulated with IL-4 or left untreated for 48 h. Subsequently, MINCLE 
expression was determined using qPCR. The data are depicted as mean ± SD of cells from four independent blood donors. Statistical significance was tested using 
a paired t-test. *p < 0.05, **p < 0.01, ***p < 0.001, †††p < 0.001.
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FigUre 2 | mrna expression of Mincle, Mcl, and Dectin-2 is downregulated by il-4 on murine antigen-presenting cells. Murine bone marrow-derived 
macrophages (BMM, black bars), thioglycolate-elicited peritoneal macrophages (PEC, gray bars), or bone marrow-derived dendritic cells (BMDC, white bars) treated 
or not with IL-4 for 48 h were analyzed by qRT-PCR for expression of mRNA encoding Mincle (a), Mcl (B), Dectin-2 (c), or Dectin-1 (D). Mean ± SD of ΔCT values 
from eight (BMM) or three (PEC and BMDC) independent experiments. Statistical significance was tested using a paired t-test. *p < 0.05, **p < 0.01, ***p < 0.001.
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mouse and human, with significant downregulation of Mincle, 
Mcl, and Dectin-2, whereas Dectin-1 was not affected or even 
upregulated by IL-4.
Differential regulation of TDB- or  
lPs-inducible Mincle expression by il-4
Expression of Mincle is strongly inducible by pattern recognition 
receptor signaling, such as TLR or CLR (4, 25, 40). Therefore, 
we examined the effect of IL-4 on Mincle mRNA expression in 
BMM treated with the TLR4 ligand LPS or the Mincle ligand TDB 
(Figure 3). Stimulation with LPS or TDB for 48 h significantly 
induced Mincle expression, as expected; the concomitant expo-
sure to IL-4 inhibited Mincle upregulation by TDB, but not by LPS 
(Figure 3A). Priming of BMM with LPS or LPS + IL-4 overnight, 
followed by removal of LPS and washing before addition of IL-4, 
also abrogated the inhibitory effect of IL-4 on Mincle expression 
(Figure 3B). Thus, the inhibitory effect of IL-4 on Mincle expres-
sion could be overcome by stimulation of macrophages with the 
TLR4 ligand LPS.
il-4 abrogates cell surface expression of 
Mincle and Mcl Protein in response to 
TDB but not lPs
We next employed flow cytometry to determine the cell surface 
levels of Mincle and Mcl in resting and stimulated macrophages 
(Figures 4A,B). Confirming previous reports (40, 41), only weak 
staining with the Mincle- and Mcl-specific monoclonal antibod-
ies (4A9 and 3A4) was detected in resting macrophages. In fact, 
using Mincle-deficient macrophages as staining controls, only 
a minimal increase in the fluorescence signal for Mincle was 
observed. Overnight stimulation with TDB caused upregulation 
of Mincle and Mcl on a significant fraction of the macrophage 
population. However, this increase was almost completely pre-
vented by co-treatment with IL-4. In contrast, the LPS-induced 
surface staining for Mincle and Mcl was found on the entire 
macrophage population and was only weakly reduced in the 
presence of IL-4. Together, the changes in cell surface protein 
levels and mRNA expression of Mincle and Mcl showed a close 
correlation.
FigUre 4 | regulation of cell surface levels of Mincle and Mcl in 
murine macrophages by il-4. Bone marrow-derived macrophages were 
analyzed for Mincle (a) and Mcl (B) surface expression 16 h after 
stimulation as indicated by using anti-Mincle (4A9) or anti-Mcl (3A4) 
primary antibodies followed by staining with APC-conjugated secondary 
antibody. (a) Histograms show Mincle surface expression in C57BL/6 
BMMs (wt) stimulated with TDB or LPS or left untreated (Mock) in 
presence (gray filled) or absence (red filled) of IL-4 as indicated. Mincle−/− 
BMMs (blue dotted) were stimulated with TDB or LPS or left untreated and 
used as negative control. Histograms are from one representative 
experiment. Scatter plot shows Mincle expression depicted as percentage 
of APC-positive cells from C57BL/6 BMMs after stimulation with TDB or 
LPS in presence or absence of IL-4 or left untreated (Mock). Data are 
depicted from two independent experiments performed in duplicates (filled 
symbols: exp. 1, open symbols: exp. 2). (B) Histograms and scatter plot 
show Mcl surface expression, respectively. Cells were treated as described 
in (a). Statistical significance was tested using an unpaired t-test. 
**p < 0.01, ***p < 0.001.
FigUre 3 | lPs overcomes il-4-induced downregulation of Mincle 
mrna expression. (a) Murine bone marrow-derived macrophages were 
treated with TDB or LPS, with or without IL-4, or were left untreated for 48 h. 
(B) LPS-priming abrogates the effect of IL-4 on Mincle expression. Bone 
marrow-derived murine macrophages were primed overnight with LPS 
(P: LPS) or left untreated (P: -). The next day, LPS was washed off, the cells 
were re-plated and cultivated for 48 h with or without IL-4. Mincle expression 
was determined with qPCR. The data are depicted as mean ± SD of ΔCT 
values from five independent experiments. Statistical significance was tested 
using a paired t-test. **p < 0.01.
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il-4 inhibits g-csF and TnF expression 
and secretion by Macrophages in 
response to TDB
We reasoned that inhibition of Mincle expression in mac-
rophages treated with IL-4 may functionally impair the response 
to the Mincle ligand TDB. To test this hypothesis, we determined 
the levels of the cytokines G-CSF and TNF, which are robustly 
secreted by macrophages stimulated with TDB or with LPS 
although the levels varied considerably between independent 
experiments (Figures  5A,B). Macrophages treated with IL-4 
or media alone did not produce significant amounts of G-CSF 
or TNF (data not shown). Concomitant treatment with IL-4 
strongly and consistently inhibited the production of both 
cytokines in response to TDB (Figures 5A,B). In contrast, LPS-
induced G-CSF was inhibited less strongly by IL-4 (Figure 5A), 
and the LPS-induced release of TNF was not affected by IL-4 
(Figure 5B).
FigUre 5 | il-4 inhibits TDB-induced cytokine production in murine macrophages. Bone marrow-derived macrophages were stimulated for 24 h with TDB 
or LPS in the presence or absence of IL-4. Cytokine levels in cell culture supernatant were quantified using ELISA [(a), G-CSF, and (B), TNF]. (a,B) Depicted are 
mean ELISA values of replicates from six independent experiments. Supernatants of BMM treated with media or IL-4 alone did not contain significant amounts of 
G-CSF or TNF (data not shown). Statistical significance of the effect of IL-4 on stimulation with TDB and LPS, respectively, was tested using a two-sided paired 
t-test. *p < 0.05, ***p < 0.001.
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negative regulation of Mincle expression 
and Target gene expression by il-4 
requires stat6
IL-4 triggers Jak-Stat signaling, with Stat6 being the pivotal tran-
scription factor for IL-4-induced gene expression (42). We inves-
tigated whether the inhibitory effect of IL-4 was also dependent 
on this transcription factor by using Stat6−/− BMM in comparison 
to the respective Balb/c wild type control BMM (Figure 6). The 
Stat6 genotype had no effect on the basal (data not shown) or 
TDB-induced Mincle expression (Figure  6A). However, IL-4 
inhibited the basal (data not shown) and TDB-induced Mincle 
expression in Balb/c BMM, but not in Stat6−/− BMM (Figure 6A). 
Similarly, the TDB-inducible expression of G-CSF at the mRNA 
and protein level was strongly inhibited in Balb/c BMM, but not 
in Stat6−/− BMM, where in fact a moderate increase in G-CSF 
protein secretion production was evident (Figures 6B,C).
DiscUssiOn
Expression of pattern recognition receptors is a prerequisite for 
sensitive detection of microbial pathogens and is often restricted 
to specialized cell types of the innate immune system. While the 
CLR Mincle, Dectin-2, and Mcl are all expressed in myeloid cells, 
their expression levels are differentially affected by microbial 
and inflammatory stimuli. In this manuscript, we show that 
the prototypical Th2 cytokine IL-4 downregulates expression 
of these members of the Dectin-2 family, but not of other CLR, 
e.g., Dectin-1. Importantly, this inhibitory effect of IL-4 was 
conserved across species, as it was detected in human as well as 
murine APC. Reduced receptor expression may be functionally 
relevant, because production of cytokines in response to the 
Mincle ligand TDB was reduced in IL-4-treated macrophages. 
Our findings raise several questions concerning the mechanism 
and potential consequences of Dectin-2 family regulation by IL-4 
during immune responses.
Signaling by the IL-4 receptor activates the transcrip-
tion factor Stat6, which is required for most transcriptional 
responses (42). Therefore, the dependence of negative regula-
tion of Mincle expression on Stat6 was not surprising. Further 
investigation will be required to determine in detail how Stat6 
mediates directly or indirectly the decrease in Mincle mRNA 
expression. One possibility is that Stat6 interferes with the 
recruitment of activating transcription factors to the promoter/
enhancer regions of Mincle, Mcl, and Dectin-2. The transcrip-
tion factor C/EBPβ is essential for the inducible expression of 
Mincle, as shown already by Matsumoto et al. in 1999 (25), but 
also for upregulation of Dectin-2 and Mcl in response to TDB, 
whereas it is not required for Dectin-1 expression (26). Thus, 
the inhibitory effect of IL-4 and the requirement for C/EBPβ 
in inducible receptor expression correlate. It is conceivable 
that IL-4 may downregulate C/EBPβ at the transcriptional or 
post-transcriptional level in macrophages. Stat6 and C/EBPβ 
cooperate in the induction of several genes associated with Th2 
responses (43) and alternative macrophage activation, such as 
Arginase-1 (44, 45). However, to our knowledge, no inhibition 
of C/EBPβ-dependent transcriptional responses by Stat6 has 
been described to date. To answer these questions, chromatin 
immunoprecipitation assays for direct binding of C/EBPβ and 
Stat6 to the promoter regions of Mincle, Mcl, and Dectin-2 will 
be required in future experiments.
Although IL-4 potently inhibited Mincle expression dur-
ing differentiation of DC from human monocytes or in mouse 
macrophages, strikingly, the concurrent stimulation or priming 
of macrophages with the TLR4 ligand LPS overcame the IL-4 
effect and prevented Mincle downregulation (Figure 3). It is pos-
sible that LPS interferes with IL-4 signaling through induction of 
negative regulators, such as Socs1 (46, 47). However, LPS did not 
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FigUre 6 | il-4-mediated inhibition of TDB-induced Mincle expression and g-csF production is sTaT6-dependent. Bone marrow-derived macrophages 
from STAT6-deficient mice and Balb/c wild-type controls were stimulated for 48 h with TDB in the presence or absence of IL-4. Mincle and G-CSF expression was 
determined by qPCR (a,c), and G-CSF concentration in the cell supernatant was obtained using ELISA (B). ELISA values were normalized to TDB-induced G-CSF 
production. Mean ± SD of four independent experiments. Statistical significance was tested using a paired t-test. *p < 0.05, **p < 0.01.
block the induction of IL-4 induced Arginase-1 expression but 
rather synergistically induced it (data not shown), suggesting that 
the abrogation of the inhibitory IL-4 effect on Mincle expression 
likely involves other mechanisms. Regardless of the mechanism, 
it appears that TLR ligands make macrophages unresponsive to 
IL-4-triggered downregulation of Mincle expression. This effect 
would be consistent with the notion that the presence of TLR 
ligands signals the requirement for continued high level expres-
sion of CLR, regardless of other signals which otherwise would 
reduce their expression.
We have also shown here that macrophages treated with IL-4 
not only express less Mincle but also fail to respond to TDB 
stimulation with upregulation of Mincle and Mcl (Figures 3 and 
4), and of the cytokines G-CSF and TNF (Figure 5), indicating 
that reduced receptor expression may lead to weaker mac-
rophage activation in response to mycobacterial cord  factor. 
It  remains  to be tested in the future whether IL-4-induced 
downregulation of Mincle, Mcl, and Dectin-2 functionally 
impairs innate recognition of and the response to mycobacteria 
and fungi. From a technical point of view, our results also 
 suggest that the use of growth factors and cytokines in protocols 
for generation of DC and macrophages, i.e. inclusion of IL-4 or 
not, may have strong effects on the response to CLR ligands. In 
the case of mycobacteria, the combined recognition of TDM 
by Mincle and Mcl, and of manLAM by Dectin-2, would be 
affected by IL-4, which may lead to compromised macrophage 
responsiveness to mycobacteria. It is interesting to speculate 
that in Th2-primed individuals reduced expression of Mincle, 
Mcl, and Dectin-2 on myeloid cells may occur, which could 
impair the detection of mycobacteria, and thereby could con-
tribute to increased susceptibility to mycobacterial infection. 
Coinfection with helminths and M. tuberculosis is prevalent 
in many parts of the world. Epidemiological data show that 
exposure of household contacts to patients with active pulmo-
nary TB resulted in higher risk to develop latent tuberculosis 
in the case of concurrent helminth infection, consistent with 
an impaired capacity of the innate immune cells, in this case 
alveolar macrophages, to kill mycobacteria upon inhalation (48). 
9Hupfer et al. IL-4 Downregulates Mincle
Frontiers in Immunology | www.frontiersin.org October 2016 | Volume 7 | Article 423
reFerences
1. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. 
Nature (2001) 413:36–7. doi:10.1038/35099612 
2. Kerscher B, Willment JA, Brown GD. The dectin-2 family of c-type lectin-like 
receptors: an update. Int Immunol (2013) 25:271–7. doi:10.1093/intimm/
dxt006 
3. Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, 
et  al. Direct recognition of the mycobacterial glycolipid, trehalose dimyco-
late, by c-type lectin mincle. J Exp Med (2009) 206:2879–88. doi:10.1084/
jem.20091750 
4. Schoenen H, Bodendorfer B, Hitchens K, Manzanero S, Werninghaus K, 
Nimmerjahn F, et  al. Cutting edge: Mincle is essential for recognition and 
adjuvanticity of the mycobacterial cord factor and its synthetic analog 
trehalose-dibehenate. J Immunol (2010) 184:2756–60. doi:10.4049/
jimmunol.0904013 
5. Bugarcic A, Hitchens K, Beckhouse AG, Wells CA, Ashman RB, Blanchard H. 
Human and mouse macrophage-inducible C-type lectin (Mincle) bind 
Candida albicans. Glycobiology (2008) 18:679–85. doi:10.1093/glycob/cwn046 
6. Vijayan D, Radford KJ, Beckhouse AG, Ashman RB, Wells CA. Mincle polar-
izes human monocyte and neutrophil responses to Candida albicans. Immunol 
Cell Biol (2012) 90:889–95. doi:10.1038/icb.2012.24 
7. Wells CA, Salvage-Jones JA, Li X, Hitchens K, Butcher S, Murray RZ, et al. The 
macrophage-inducible c-type lectin, mincle, is an essential component of the 
innate immune response to Candida albicans. J Immunol (2008) 180:7404–13. 
doi:10.4049/jimmunol.180.11.7404 
8. Ishikawa T, Itoh F, Yoshida S, Saijo S, Matsuzawa T, Gonoi T, et al. Identification 
of distinct ligands for the C-type lectin receptors mincle and dectin-2 in 
the pathogenic fungus malassezia. Cell Host Microbe (2013) 13:477–88. 
doi:10.1016/j.chom.2013.03.008 
9. Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishikawa E, Sakuma M, 
et  al. C-type lectin mincle is an activating receptor for pathogenic fungus, 
malassezia. Proc Natl Acad Sci U S A (2009) 106:1897–902. doi:10.1073/
pnas.0805177106 
10. Sousa Mda G, Reid DM, Schweighoffer E, Tybulewicz V, Ruland J, Langhorne J, 
et al. Restoration of pattern recognition receptor costimulation to treat chro-
moblastomycosis, a chronic fungal infection of the skin. Cell Host Microbe 
(2011) 9:436–43. doi:10.1016/j.chom.2011.04.005 
11. Wevers BA, Kaptein TM, Zijlstra-Willems EM, Theelen B, Boekhout T, 
Geijtenbeek TB, et  al. Fungal engagement of the C-type lectin mincle 
suppresses dectin-1-induced antifungal immunity. Cell Host Microbe (2014) 
15:494–505. doi:10.1016/j.chom.2014.03.008 
12. Miyake Y, Toyonaga K, Mori D, Kakuta S, Hoshino Y, Oyamada A, et al. C-type 
lectin mcl is an fcrgamma-coupled receptor that mediates the adjuvanticity 
of mycobacterial cord factor. Immunity (2013) 38:1050–62. doi:10.1016/ 
j.immuni.2013.03.010 
13. Wilson GJ, Marakalala MJ, Hoving JC, van Laarhoven A, Drummond RA, 
Kerscher B, et  al. The C-type lectin receptor Clecsf8/Clec4d is a key com-
ponent of anti-mycobacterial immunity. Cell Host Microbe (2015) 17:252–9. 
doi:10.1016/j.chom.2015.01.004 
14. Graham LM, Gupta V, Schafer G, Reid DM, Kimberg M, Dennehy KM, et al. 
The C-type lectin receptor CLECSF8 (CLEC4D) is expressed by myeloid 
cells and triggers cellular activation through Syk kinase. J Biol Chem (2012) 
287:25964–74. doi:10.1074/jbc.M112.384164 
15. Robinson MJ, Osorio F, Rosas M, Freitas RP, Schweighoffer E, Gross O, 
et al. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for th17 
responses to fungal infection. J Exp Med (2009) 206:2037–51. doi:10.1084/
jem.20082818 
16. Taylor PR, Reid DM, Heinsbroek SE, Brown GD, Gordon S, Wong SY. Dectin-2 
is predominantly myeloid restricted and exhibits unique activation-depen-
dent expression on maturing inflammatory monocytes elicited in vivo. Eur 
J Immunol (2005) 35:2163–74. doi:10.1002/eji.200425785 
17. Yonekawa A, Saijo S, Hoshino Y, Miyake Y, Ishikawa E, Suzukawa M, et al. 
Dectin-2 is a direct receptor for mannose-capped lipoarabinomannan of 
mycobacteria. Immunity (2014) 41:402–13. doi:10.1016/j.immuni.2014.08.005 
18. Ritter M, Gross O, Kays S, Ruland J, Nimmerjahn F, Saijo S, et al. Schistosoma 
mansoni triggers dectin-2, which activates the nlrp3 inflammasome and alters 
adaptive immune responses. Proc Natl Acad Sci U S A (2010) 107:20459–64. 
doi:10.1073/pnas.1010337107 
19. Sancho D, Reis e Sousa C. : Signaling by myeloid C-type lectin receptors 
in immunity and homeostasis. Annu Rev Immunol (2012) 30:491–529. 
doi:10.1146/annurev-immunol-031210-101352 
20. Werninghaus K, Babiak A, Gross O, Holscher C, Dietrich H, Agger EM, et al. 
Adjuvanticity of a synthetic cord factor analogue for subunit mycobacterium 
tuberculosis vaccination requires fcrgamma-Syk-Card9-dependent innate 
immune activation. J Exp Med (2009) 206:89–97. doi:10.1084/jem.20081445 
21. Desel C, Werninghaus K, Ritter M, Jozefowski K, Wenzel J, Russkamp N, 
et  al. The mincle-activating adjuvant TDB induces Myd88-dependent Th1 
and Th17 responses through IL-1R signaling. PLoS One (2013) 8:e53531. 
doi:10.1371/journal.pone.0053531 
22. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, 
Tsoni SV, et al. Syk- and CARD9-dependent coupling of innate immunity to 
the induction of t helper cells that produce interleukin 17. Nat Immunol (2007) 
8:630–8. doi:10.1038/ni1460 
23. Shenderov K, Barber DL, Mayer-Barber KD, Gurcha SS, Jankovic D, Feng CG, 
et al. Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant 
activity of mycobacteria through mincle/CARD9 signaling and the inflam-
masome. J Immunol (2013) 190:5722–30. doi:10.4049/jimmunol.1203343 
24. Schweneker K, Gorka O, Schweneker M, Poeck H, Tschopp J, Peschel C, et al. 
The mycobacterial cord factor adjuvant analogue trehalose-6,6’-dibehenate 
(TDB) activates the nlrp3 inflammasome. Immunobiology (2013) 218:664–73. 
doi:10.1016/j.imbio.2012.07.029 
In  addition,  anti-helminthic  treatment of people latently 
infected with M. tuberculosis led to marked improvement of 
T cell responses, which could also be at least partially due to 
upregulation of CLR expression with loss of helminth-induced 
IL-4 (49, 50). Indeed, such a mechanism appears to operate for 
levels of TLR2 and TLR9 (49). In the mouse model of coin-
fection, experimental evidence for increased susceptibility of 
helminth-infected animals challenged with M. tuberculosis has 
been obtained for increased mycobacterial burden for coinfec-
tion with Schistosoma mansoni or Nippostrongylus brasiliensis 
(32, 51). While helminth-induced IL-4 probably acts at multiple 
levels on the innate as well as the development of adaptive 
immune responses (52), the possible contribution of impaired 
expression of Mincle, Mcl, and Dectin-2 to modulation of the 
host response in tuberculosis in individuals co-infected with 
worms should therefore be explored in future studies.
aUThOr cOnTriBUTiOns
TH, JS, and JO performed experiments and analyzed data. KJ 
performed experiments. DV provided critical reagents. JO and 
RL designed experiments and wrote the manuscript.
acKnOWleDgMenTs
The present work was performed in (partial) fulfillment of the 
requirements for obtaining the degree “Dr. med.” of TH. Support 
by the Deutsche Forschungsgemeinschaft to the lab of RL is grate-
fully acknowledged (SFB 796, TP B6; GRK 1660, TP A2). TH was 
supported by a doctoral fellowship provided by the IZKF of the 
Medical Faculty at the Friedrich-Alexander-University Erlangen-
Nürnberg. We thank Dr. Janet Willment for the generous gift of 
anti-Mcl antibody.
10
Hupfer et al. IL-4 Downregulates Mincle
Frontiers in Immunology | www.frontiersin.org October 2016 | Volume 7 | Article 423
25. Matsumoto M, Tanaka T, Kaisho T, Sanjo H, Copeland NG, Gilbert DJ, et al. 
A novel lps-inducible C-type lectin is a transcriptional target of NF-IL6 in 
macrophages. J Immunol (1999) 163:5039–48. 
26. Schoenen H, Huber A, Sonda N, Zimmermann S, Jantsch J, Lepenies B, 
et  al. Differential control of mincle-dependent cord factor recognition and 
macrophage responses by the transcription factors C/Ebpbeta and Hif1alpha. 
J Immunol (2014) 193:3664–75. doi:10.4049/jimmunol.1301593 
27. Lee WB, Kang JS, Yan JJ, Lee MS, Jeon BY, Cho SN, et al. Neutrophils pro-
mote mycobacterial trehalose dimycolate-induced lung inflammation via the 
mincle pathway. PLoS Pathog (2012) 8:e1002614. doi:10.1371/journal.ppat. 
1002614 
28. Ostrop J, Jozefowski K, Zimmermann S, Hofmann K, Strasser E, Lepenies B, 
et al. Contribution of mincle-Syk signaling to activation of primary human 
APCS by mycobacterial cord factor and the novel adjuvant TDB. J Immunol 
(2015) 195:2417–28. doi:10.4049/jimmunol.1500102 
29. Gavino AC, Chung JS, Sato K, Ariizumi K, Cruz PD Jr. Identification and 
expression profiling of a human C-type lectin, structurally homologous to 
mouse dectin-2. Exp Dermatol (2005) 14:281–8. doi:10.1111/j.0906-6705.2005. 
00312.x 
30. Van Dyken SJ, Locksley RM. Interleukin-4- and interleukin-13-mediated alter-
natively activated macrophages: roles in homeostasis and disease. Annu Rev 
Immunol (2013) 31:317–43. doi:10.1146/annurev-immunol-032712-095906 
31. Romani L. Immunity to fungal infections. Nat Rev Immunol (2011) 11:275–88. 
doi:10.1038/nri2939 
32. Potian JA, Rafi W, Bhatt K, McBride A, Gause WC, Salgame P. Preexisting 
helminth infection induces inhibition of innate pulmonary anti-tuberculosis 
defense by engaging the IL-4 receptor pathway. J Exp Med (2011) 208:1863–74. 
doi:10.1084/jem.20091473 
33. Salgame P, Yap GS, Gause WC. Effect of helminth-induced immunity on infec-
tions with microbial pathogens. Nat Immunol (2013) 14:1118–26. doi:10.1038/
ni.2736 
34. Willment JA, Lin HH, Reid DM, Taylor PR, Williams DL, Wong SY, et  al. 
Dectin-1 expression and function are enhanced on alternatively activated 
and GM-CSF-treated macrophages and are negatively regulated by IL-10, 
dexamethasone, and lipopolysaccharide. J Immunol (2003) 171:4569–73. 
doi:10.4049/jimmunol.171.11.6297-b 
35. Pfeiffer IA, Zinser E, Strasser E, Stein MF, Dorrie J, Schaft N, et  al. 
Leukoreduction system chambers are an efficient, valid, and economic 
source of functional monocyte-derived dendritic cells and lymphocytes. 
Immunobiology (2013) 218:1392–401. doi:10.1016/j.imbio.2013.07.005 
36. Hammer M, Mages J, Dietrich H, Schmitz F, Striebel F, Murray PJ, et al. Control 
of dual-specificity phosphatase-1 expression in activated macrophages by 
IL-10. Eur J Immunol (2005) 35:2991–3001. doi:10.1002/eji.200526192 
37. Ozeki Y, Tsutsui H, Kawada N, Suzuki H, Kataoka M, Kodama T, et  al. 
Macrophage scavenger receptor down-regulates mycobacterial cord 
 factor-induced proinflammatory cytokine production by alveolar and 
hepatic macrophages. Microb Pathog (2006) 40:171–6. doi:10.1016/ 
j.micpath.2005.12.006 
38. Kerscher B, Wilson GJ, Reid DM, Mori D, Taylor JA, Besra GS, et  al. 
Mycobacterial receptor, Clec4d (Clecsf8, MCL), is coregulated with mincle 
and upregulated on mouse myeloid cells following microbial challenge. Eur 
J Immunol (2016) 46:381–9. doi:10.1002/eji.201545858 
39. Schleicher U, Paduch K, Debus A, Obermeyer S, Konig T, Kling JC, et  al. 
TNF-mediated restriction of arginase 1 expression in myeloid cells triggers 
type 2 NO synthase activity at the site of infection. Cell Rep (2016) 15:1062–75. 
doi:10.1016/j.celrep.2016.04.001 
40. Kerscher B, Dambuza IM, Christofi M, Reid DM, Yamasaki S, Willment 
JA, et  al. Signalling through myd88 drives surface expression of the 
mycobacterial receptors MCL (Clecsf8, Clec4d) and mincle (Clec4e) follow-
ing microbial stimulation. Microbes Infect (2016) 18(7–8):505–9. doi:10.1016/ 
j.micinf.2016.03.007 
41. Miyake Y, Oh-Hora M, Yamasaki S. C-type lectin receptor MCL facilitates 
mincle expression and signaling through complex formation. J Immunol 
(2015) 194:5366–74. doi:10.4049/jimmunol.1402429 
42. Goenka S, Kaplan MH. Transcriptional regulation by stat6. Immunol Res 
(2011) 50:87–96. doi:10.1007/s12026-011-8205-2 
43. Mikita T, Kurama M, Schindler U. Synergistic activation of the germline 
epsilon promoter mediated by stat6 and c/ebp beta. J Immunol (1998) 
161:1822–8. 
44. Gray MJ, Poljakovic M, Kepka-Lenhart D, Morris SM Jr. Induction of arginase 
I transcription by IL-4 requires a composite DNA response element for STAT6 
and C/EBPbeta. Gene (2005) 353:98–106. doi:10.1016/j.gene.2005.04.004 
45. Pauleau AL, Rutschman R, Lang R, Pernis A, Watowich SS, Murray 
PJ. Enhancer-mediated control of macrophage-specific arginase I expression. 
J Immunol (2004) 172:7565–73. doi:10.4049/jimmunol.172.12.7565 
46. Dickensheets HL, Venkataraman C, Schindler U, Donnelly RP. Interferons 
inhibit activation of stat6 by interleukin 4 in human monocytes by induc-
ing SOCS-1 gene expression. Proc Natl Acad Sci U S A (1999) 96:10800–5. 
doi:10.1073/pnas.96.19.10800 
47. Losman JA, Chen XP, Hilton D, Rothman P. Cutting edge: SOCS-1 is a potent 
inhibitor of IL-4 signal transduction. J Immunol (1999) 162:3770–4. 
48. Verhagen LM, Hermans PW, Warris A, de Groot R, Maes M, Villalba JA, 
et  al. Helminths and skewed cytokine profiles increase tuberculin skin test 
positivity in warao amerindians. Tuberculosis (Edinb) (2012) 92:505–12. 
doi:10.1016/j.tube.2012.07.004 
49. Babu S, Bhat SQ, Kumar NP, Anuradha R, Kumaran P, Gopi PG, et  al. 
Attenuation of toll-like receptor expression and function in latent tuber-
culosis by coexistent filarial infection with restoration following antifilarial 
chemotherapy. PLoS Negl Trop Dis (2009) 3:e489. doi:10.1371/journal.pntd. 
0000489 
50. Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S. Effect of 
deworming on human t cell responses to mycobacterial antigens in  helminth- 
exposed  individuals before and after Bacille Calmette-Guerin (BCG) 
 vaccination. Clin Exp Immunol (2001) 123:219–25. doi:10.1046/j.1365-2249. 
2001.01446.x 
51. Frantz FG, Rosada RS, Peres-Buzalaf C, Perusso FR, Rodrigues V, Ramos SG, 
et al. Helminth coinfection does not affect therapeutic effect of a DNA vaccine 
in mice harboring tuberculosis. PLoS Negl Trop Dis (2010) 4:e700. doi:10.1371/
journal.pntd.0000700 
52. George PJ, Anuradha R, Kumar NP, Sridhar R, Banurekha VV, Nutman TB, 
et  al. Helminth infections coincident with active pulmonary tuberculosis 
inhibit mono- and multifunctional Cd4+ and Cd8+ T cell responses in a 
process dependent on IL-10. PLoS Pathog (2014) 10:e1004375. doi:10.1371/
journal.ppat.1004375 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Hupfer, Schick, Jozefowski, Voehringer, Ostrop and Lang. This 
is an open-access article distributed under the terms of the Creative Commons 
Attribution License (CC BY). The use, distribution or reproduction in other forums 
is permitted, provided the original author(s) or licensor are credited and that the 
original publication in this journal is cited, in accordance with accepted academic 
practice. No use, distribution or reproduction is permitted which does not comply 
with these terms.
